longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

ESSEX BIO-TECH

01061

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 4.35, below the reasonable range, cheaper than 98.72% of the time in the past 3 years, and the industry ranks 4/78, the industry Median -5.53.

4.35xP/E
HK$2.05Stock price
HK$0.47Earnings per share
4.35xP/E
Stock priceHK$2.05Earnings per shareHK$0.47

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
5.92x
Typical range
4.93x–7.93x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0166332498664

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09995HKREMEGEN
6.40x537.83%HK$42.90B
01530HK3SBIO
4.30x71.15%HK$40.94B
01167HKJACOBIO-B
7.90x--HK$4.67B
02509HKQYUNS-B
5.87x37.29%HK$3.69B
06998HKEDDING GENOR
13.88x--HK$3.50B
02197HKCLOVER BIO-B
2.63x--HK$2.58B
02566HKJIUYUAN GENE
8.07x--HK$1.30B
01061HKESSEX BIO-TECH
4.35x1.60%HK$1.16B
00690HKUNI-BIO GROUP
9.23x--HK$447.84M
08158HKCRMI
2.00x--HK$55.07M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.